No picture, placeholder image
No picture, placeholder image
Førsteamanuensis Klinihkalaš medisiinna instituhtta mona.d.gundersen@uit.no

Mona Dixon Gundersen



  • Kay-Martin Johnsen, Jon Florholmen, Øystein Kittel Moe, Mona Dixon Gundersen, Julia Beilfuss, Hege Kileng et al.:
    Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study
    BMC Gastroenterology 2022 ARKIV / DOI
  • Rasmus Goll, Øystein Kittel Moe, Kay-Martin Johnsen, Renate Weenås Meyer, Joachim Friestad, Mona Dixon Gundersen et al.:
    Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease
    BMC Gastroenterology 2022 ARKIV / DOI
  • Mona Dixon Gundersen, Kenneth Bowitz Larsen, Kay-Martin Johnsen, Rasmus Goll, Jon Florholmen, Guttorm Haraldsen :
    Hypo-osmotic stress induces the epithelial alarmin IL-33 in the colonic barrier of ulcerative colitis
    Scientific Reports 2022 ARKIV / DOI
  • Christian Børde Arkteg, Rasmus Goll, Mona Dixon Gundersen, Endre Anderssen, Christopher Graham Fenton, Jon Florholmen :
    Mucosal gene transcription of ulcerative colitis in endoscopic remission
    Scandinavian Journal of Gastroenterology 2020 ARKIV / DOI
  • Jon Florholmen, Kay-Martin Johnsen, Renate Weenås Meyer, Trine Olsen, Øystein Kittel Moe, Petter Tandberg et al.:
    Discovery and validation of mucosal TNF expression combined with histological score-a biomarker for personalized treatment in ulcerative colitis
    BMC Gastroenterology 2020 ARKIV / DOI
  • Mona Dixon Gundersen, Rasmus Goll, Christopher Graham Fenton, Endre Anderssen, Sveinung Wergeland Sørbye, Jon Florholmen et al.:
    Fibrosis Mediators in the Colonic Mucosa of Acute and Healed Ulcerative Colitis
    Clinical and Translational Gastroenterology 2019 ARKIV / DOI
  • Kay-Martin Johnsen, Rasmus Goll, Vegar Hansen, Trine Olsen, Renathe Rismo, Richard Heitmann et al.:
    Repeated intensified infliximab induction – results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm
    European Journal of Gastroenterology and Hepathology 2017 DOI
  • Mona Dixon Gundersen, Rasmus Goll, Johanna Hol, Trine Olsen, Renathe Rismo, Sveinung Wergeland Sørbye et al.:
    Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis
    Scientific Reports 2016 ARKIV / DOI
  • Trine Olsen, Renathe Rismo, Mona Dixon Gundersen, Eyvind Jakob Paulssen, Knut Johnsen, Jan-Magnus Kvamme et al.:
    Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis
    Cytokine 2016 DOI
  • Cui Guanglin, Haili Qi, Mona Dixon Gundersen, Hang Yang, Ingrid B Christiansen, Sveinung Wergeland Sørbye et al.:
    Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer
    Cancer Immunology and Immunotherapy 17. Oct 2014 ARKIV / FULLTEKST / DOI
  • Mona Dixon Gundersen, R Yaseen, Rune Midgard :
    Incidence and Clinical Features of Amyotrophic Lateral Sclerosis in More and Romsdal County, Norway
    Neuroepidemiology 2011 DOI
  • Mona Dixon Gundersen, Rasmus Goll, Jon Florholmen, Ruth H Paulssen :
    Mucosal healing in active ulcerative colitis treated with infliximab to disease remission
    Inflammatory Bowel Diseases 2016

  • The 50 latest publications is shown on this page. See all publications in Cristin here →